Grape Seed Extract for Neurodegenerative Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's lack effective pharmaceutical compositions to prevent or slow disease progression, with existing medications offering only temporary symptomatic relief and significant side effects.
Innovation Solution
Administration of a pharmaceutical composition comprising grape seed extract or compounds derived therefrom, which inhibits the misfolding, accumulation, and aggregation of amyloid beta and tau proteins, thereby reducing their toxic effects in the brain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current medications are used to treat neurodegenerative diseases, then symptomatic relief is provided, but the treatment duration is temporary and side effects are significant
Solution Approach 1:
The patent uses grape seed extract as an intermediary substance that targets the underlying pathological mechanisms (protein misfolding, aggregation, and deposition) rather than merely treating symptoms. This mediator approach addresses the root cause of neurodegenerative diseases, providing more durable therapeutic effects compared to conventional symptomatic treatments.
Solution Approach 2:
The invention focuses on preventing protein misfolding and aggregation before they lead to irreversible neuronal damage. By intervening early in the pathological process through grape seed extract administration, the treatment aims to prevent disease progression rather than merely providing temporary symptomatic relief.
2Reliability
If current medications are used to treat neurodegenerative diseases, then symptomatic relief is provided, but side effects are significant
Solution Approach 1:
The patent employs natural polyphenolic compounds from grape seed extract as safe, biocompatible alternatives to conventional pharmaceuticals. These natural compounds provide therapeutic benefits without the significant side effects associated with current medications, offering a safer treatment profile.
Solution Approach 2:
The invention converts the antioxidant properties of grape seed extract, which are naturally beneficial, into a therapeutic mechanism that counteracts oxidative stress and protein aggregation in neurodegenerative diseases. This approach transforms a naturally occurring protective mechanism into a targeted therapy.
3Reliability
If pharmaceutical compositions are developed to target protein aggregation, then disease progression may be slowed, but the complexity of the treatment increases
Solution Approach 1:
The patent utilizes polyphenolic compounds from grape seed extract that exhibit multiple therapeutic mechanisms simultaneously: antioxidant activity, anti-aggregation properties, and neuroprotective effects. This multi-functionality allows a single composition to address multiple pathological aspects of neurodegenerative diseases without requiring complex combination therapies.
Data Source
AI summary
The present invention provide a method for the prevention and treatment of a neurodegenerative disease including Alzheimer's Disease, Huntington's Disease, and Parkinson's Disease, using a grape seed extract or one or more compounds derived therefrom. In particular, the present invention provides a method to treat a patient diagnosed with, or at the risk of developing, a neurodegenerative disease by administering a pharmaceutical composition comprising a grape seed extract or one or more compounds derived therefrom to the patient in a therapeutic amount to reduce the accumulation, aggregation or deposition of amyloid beta or its oligomers, and/or to reduce the misfolding, accumulation and/or aggregation of tau proteins or other proteins.